These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28535716)

  • 21. Proper inference from Simon's two-stage designs.
    Koyama T; Chen H
    Stat Med; 2008 Jul; 27(16):3145-54. PubMed ID: 17960777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal sequential enrichment designs for phase II clinical trials.
    Zang Y; Yuan Y
    Stat Med; 2017 Jan; 36(1):54-66. PubMed ID: 27640874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal flexible designs in phase II clinical trials.
    Chen TT; Ng TH
    Stat Med; 1998 Oct; 17(20):2301-12. PubMed ID: 9819829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graphical search for two-stage designs for phase II clinical trials.
    Jung SH; Carey M; Kim KM
    Control Clin Trials; 2001 Aug; 22(4):367-72. PubMed ID: 11514038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A modification of Simon's optimal design for phase II trials when the criterion is median sample size.
    Hanfelt JJ; Slack RS; Gehan EA
    Control Clin Trials; 1999 Dec; 20(6):555-66. PubMed ID: 10588296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
    Berry SM; Broglio KR; Groshen S; Berry DA
    Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curtailed two-stage designs in Phase II clinical trials.
    Chi Y; Chen CM
    Stat Med; 2008 Dec; 27(29):6175-89. PubMed ID: 18816510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive sequential design for phase II single-arm oncology trials: an expansion of Simon's design.
    Gao P; Zhang W
    J Biopharm Stat; 2024 Apr; ():1-15. PubMed ID: 38619921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design.
    Belin L; Broët P; De Rycke Y
    PLoS One; 2015; 10(9):e0137586. PubMed ID: 26368810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal, minimax and admissible two-stage design for phase II oncology clinical trials.
    Qin F; Wu J; Chen F; Wei Y; Zhao Y; Jiang Z; Bai J; Yu H
    BMC Med Res Methodol; 2020 May; 20(1):126. PubMed ID: 32434577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches to handling data when a phase II trial deviates from the pre-specified Simon's two-stage design.
    Wu Y; Shih WJ
    Stat Med; 2008 Dec; 27(29):6190-208. PubMed ID: 18800338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An optimal three-stage design for phase II clinical trials.
    Ensign LG; Gehan EA; Kamen DS; Thall PF
    Stat Med; 1994 Sep; 13(17):1727-36. PubMed ID: 7997706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Admissible two-stage designs for phase II cancer clinical trials.
    Jung SH; Lee T; Kim K; George SL
    Stat Med; 2004 Feb; 23(4):561-9. PubMed ID: 14755389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promising zone two-stage design for a single-arm study with binary outcome.
    Shan G
    Stat Methods Med Res; 2023 Jun; 32(6):1159-1168. PubMed ID: 36998163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An efficient algorithm to determine the optimal two-stage randomized multinomial designs in oncology clinical trials.
    Zhang Y; Mietlowski W; Chen B; Wang Y
    J Biopharm Stat; 2011 Jan; 21(1):56-65. PubMed ID: 21191854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interval and point estimation in adaptive Phase II trials with binary endpoint.
    Nhacolo A; Brannath W
    Stat Methods Med Res; 2019 Sep; 28(9):2635-2648. PubMed ID: 29921157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research design for patient selection in clinical trials phase II].
    Kramar A; Potvin D; Hill C
    Rev Epidemiol Sante Publique; 1996 Aug; 44(4):364-71. PubMed ID: 8927779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial Two-stage Designs for Phase II Clinical Trials.
    Kim S; Wong WK
    Comput Stat Data Anal; 2022 May; 169():. PubMed ID: 35058669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.